Suchergebnisse - "O3J8G9O825"

PubPharm (5.512)

71

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19 : A Matched Cohort Study

enthalten in: The Journal of infectious diseases | 2024

von Butt, A. | Yan, P. | Shaikh, O. | +3

72

Daily ritonavir-boosted darunavir for viral suppression in pregnancy (DRV-P)

enthalten in: HIV medicine | 2024

von Gacic, N. | Tulloch, K. | Money, D. | +1

73

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD : Insights from a Single-Center Prospective Cohort Study

enthalten in: Viruses | 2024

von Buchynskyi, M. | Oksenych, V. | Kamyshna, I. | +1

74

Covid-19 : NICE plans to expand Paxlovid eligibility to 1.4 million more people

enthalten in: BMJ (Clinical research ed.) | 2024

von Mahase, E.

75

Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies

enthalten in: Influenza and other respiratory viruses | 2024

von Aiello, T. | Peyrony, O. | Chumbita, M. | +12

76

Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, H. | Zhou, J. | Chen, H. | +10

77

No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

enthalten in: Journal of medical virology | 2024

von Palomino-Cabrera, R. | Tejerina, F. | Molero-Salinas, A. | +9

78

Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID

enthalten in: JAMA | 2024

von Suran, M.

79

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

enthalten in: Expert review of anti-infective therapy | 2024

von Liu, T. | Wu, J. | Huang, P. | +5

80

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing : a multicenter retrospective cohort study

enthalten in: BMC infectious diseases | 2024

von Han, X. | Gao, D. | Li, C. | +18